MD240Y - Method for treating cognitive disorders - Google Patents

Method for treating cognitive disorders Download PDF

Info

Publication number
MD240Y
MD240Y MDS20100058A MDS20100058A MD240Y MD 240 Y MD240 Y MD 240Y MD S20100058 A MDS20100058 A MD S20100058A MD S20100058 A MDS20100058 A MD S20100058A MD 240 Y MD240 Y MD 240Y
Authority
MD
Moldova
Prior art keywords
cognitive disorders
cerebral hemisphere
iaeeg
micropolarization
projection
Prior art date
Application number
MDS20100058A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Виктор ЛАКУСТА
Анжела ГЫЛЯ
Виктория ЧЕРЕШ
Original Assignee
Виктор ЛАКУСТА
Анжела ГЫЛЯ
Виктория ЧЕРЕШ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Виктор ЛАКУСТА, Анжела ГЫЛЯ, Виктория ЧЕРЕШ filed Critical Виктор ЛАКУСТА
Priority to MDS20100058A priority Critical patent/MD240Y/en
Publication of MD240Y publication Critical patent/MD240Y/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to medicine, namely to the cognitive neurology and can be used for the correction of cognitive disorders.The method for treating cognitive disorders consists in carrying out the electroencephalogram, afterwards on the basis of the obtained data in the frontal lead F3 for the left cerebral hemisphere and in the frontal lead F4 for the right cerebral hemisphere is determined the integral index of the electroencephalogram (IEEG). Then, it is determined the degree of interhemispheric asymmetry (IAEEG) and if IAEEG is less than 10% and IEEGF3 and/or IEEGF4 is more than 0.7, then it is carried out the micropolarization in the projection of the vermis of cerebellum, if IAEEG is more than 10% and IEEGF3 is more than 0.7, it is carried out the micropolarization in the projection of the right cerebral hemisphere and, accordingly, if IEEGF4 is more than 0.7, it is carried out the micropolarization in the projection of the left cerebral hemisphere.
MDS20100058A 2010-03-29 2010-03-29 Method for treating cognitive disorders MD240Y (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20100058A MD240Y (en) 2010-03-29 2010-03-29 Method for treating cognitive disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20100058A MD240Y (en) 2010-03-29 2010-03-29 Method for treating cognitive disorders

Publications (1)

Publication Number Publication Date
MD240Y true MD240Y (en) 2010-07-31

Family

ID=43569027

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20100058A MD240Y (en) 2010-03-29 2010-03-29 Method for treating cognitive disorders

Country Status (1)

Country Link
MD (1) MD240Y (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD465Z (en) * 2011-06-07 2012-08-31 Виктор ЛАКУСТА Method for treatment of cognitive-affective disorders in patients with chronic migraine and asymmetry of lateral cerebral ventricles

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3504G2 (en) * 2007-05-31 2009-03-31 Виктор ЛАКУСТА Method of transcranial micropolarization
  • 2010

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3504G2 (en) * 2007-05-31 2009-03-31 Виктор ЛАКУСТА Method of transcranial micropolarization

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD465Z (en) * 2011-06-07 2012-08-31 Виктор ЛАКУСТА Method for treatment of cognitive-affective disorders in patients with chronic migraine and asymmetry of lateral cerebral ventricles

Similar Documents

Publication Publication Date Title
Wallace et al. The construct of the multisensory temporal binding window and its dysregulation in developmental disabilities
WO2014145617A3 (en) Novel uses
EA201370008A1 (en) TREATMENT OF COGNITIVE DISTURBANCES
AU2015339284A8 (en) Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
HK1213291A1 (en) Cystathionine beta-synthase enzyme for treatment of homocystinuria
PH12018501288A1 (en) Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels
MY179105A (en) Methods of treating alzheimer's disease
MX2017009091A (en) Desferrioxamine-metal complexes for the treatment of immune-related disorders.
WO2012065110A3 (en) S-protected cysteine analogs and related compounds
WO2017031067A3 (en) Biomarkers for treatment of alopecia areata
WO2014151456A3 (en) Treatment of inflammatory diseases
CA2863417A1 (en) Innate immune proteins as biomarkers for cns injury
HK1250171A1 (en) Method for detecting genomic variations using circularised mate-pair library and shotgun sequencing
MX358518B (en) Anti-asic1 antibodies and uses thereof.
WO2012012278A3 (en) Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex
WO2012074561A3 (en) Methods and compositions for the treatment of anxiety disorders, including post traumatic stress disorder (ptsd) and related central nervous system (cns) disorders
PH12015502687A1 (en) Marker for acid sphingomyelinase disorders and uses thereof
BR112015018047A8 (en) method for preparing stable compositions comprising heparinoid, acute acting anesthetic and buffer and the same
MX2016003002A (en) Methods of determining response to therapy.
GB2557471A (en) Arginine silicate inositol for improving cognitive function
EA201500294A1 (en) NOOTROP COMPOSITIONS TO IMPROVE MEMORY PROPERTIES
MX2010000938A (en) 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide for the treatment of post-traumatic stress disorder.
NZ799802A (en) Compositions for treating neurodegenerative diseases
WO2008008487A3 (en) Gene expression profiling for identification, monitoring and treatment of multiple sclerosis
MD240Y (en) Method for treating cognitive disorders

Legal Events

Date Code Title Description
KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)